Susceptibility or resistance of praziquantel in human schistosomiasis: a review (original) (raw)
Abdel-Hafeez EH, Ahmad AK, Abdulla AM, Aabdel-Wahab S, Mosalem FA (2012) Therapeutic effect of alpha lipoic acid combined with praziquantel on liver fibrosis induced by Schistosoma mansoni challenged mice. Parasitol Res 111:577–586 ArticlePubMed Google Scholar
Alonso D, Muñoz J, Gascón J, Valls ME, Corachan M (2006) Failure of standard treatment with praziquantel in two returned travelers with Schistosoma haematobium infection. Am J Trop Med Hyg 74:342–344 PubMed Google Scholar
Blackhall WJ, Liu HY, Xu M, Prichard RK, Beech RN (1998) Selection at a P-glycoprotein gene in ivermectin- and moxidectin-selected strains of Haemonchus contortus. Mol Biochem Parasitol 95:193–201 ArticlePubMedCAS Google Scholar
Blackhall WJ, Prichard RK, Beech RN (2008) P-glycoprotein selection in strains of Haemonchus contortus resistant to benzimidazoles. Vet Parasitol 152:101–107 ArticlePubMedCAS Google Scholar
Bonesso-Sabadini PI, de Souza Dias LC (2002) Altered response of strain of Schistosoma mansoni to oxamniquine and praziquantel. Mem Inst Oswaldo Cruz 97:381–385 ArticlePubMedCAS Google Scholar
Bosch IB, Wang ZX, Tao LF, Shoemaker CB (1994) Two Schistosoma mansoni cDNAs encoding ATP-binding cassette (ABC) family proteins. Mol Biochem Parasitol 65:351–356 ArticlePubMedCAS Google Scholar
Botros S, El-Lakkany N, SH Se-D, Sabra AN, Ibrahim M (2011) Comparative efficacy and bioavailability of different praziquantel brands. Exp Parasitol 127:515–521 ArticlePubMedCAS Google Scholar
Caffrey CR (2007) Chemotherapy of schistosomiasis: present and future. Curr Opin Chem Biol 11:433–439 ArticlePubMedCAS Google Scholar
Campos R, Moreira AA, Sette H Jr, Chamone DA, Da Silva LC (1976) Hycanthone resistance in a human strain of Schistosoma mansoni. Trans R Soc Trop Med Hyg 70:261–262 ArticlePubMedCAS Google Scholar
Chen MG (2005) Use of praziquantel for clinical treatment and morbidity control of schistosomiasis japonica in China: a review of 30 years’ experience. Acta Trop 96:168–176 ArticlePubMedCAS Google Scholar
Cioli D (2000) Praziquantel: is there real resistance and are there alternatives? Curr Opin Infect Dis 13:659–663 ArticlePubMedCAS Google Scholar
Coles GC, Bruce JI (1987) In vitro selection of drug resistant Schistosoma mansoni. Int J Parasitol 17:767–771 ArticlePubMedCAS Google Scholar
Coles GC, Kinoti GK (1997) Defining resistance in Schistosoma. Parasitol Today 13:57–158 Article Google Scholar
Couto FF, Coelho PM, Araújo N, Kusel JR, Katz N, Jannotti-Passos LK, Mattos AC (2011) _Schistosoma manson_i: a method for inducing resistance to praziquantel using infected Biomphalaria glabrata snails. Mem Inst Oswaldo Cruz 106:153–157 PubMedCAS Google Scholar
Danso-Appiah A, De Vlas SJ (2002) Interpreting low praziquantel cure rates of Schistosoma mansoni infections in Senegal. Trends Parasitol 18:125–129 ArticlePubMed Google Scholar
Dias LC, Olivier CE (1986) Failure at inducing resistance to schistosomicidal drugs in a Brazilian human strain of Schistosoma mansoni. Rev Inst Med Trop Sao Paulo 28:352–357 ArticlePubMedCAS Google Scholar
Doenhoff MJ, Pica-Mattoccia L (2006) Praziquantel for the treatment of schistosomiasis: its use for control in areas with endemic disease and prospects for drug resistance. Expert Rev Anti Infect Ther 4:199–210 ArticlePubMedCAS Google Scholar
Doenhoff MJ, Kusel JR, Coles GC, Cioli D (2002) Resistance of Schistosoma mansoni to praziquantel: is there a problem? Trans R Soc Trop Med Hyg 96:465–469 ArticlePubMedCAS Google Scholar
Doenhoff MJ, Cioli D, Utzinger J (2008) Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. Curr Opin Infect Dis 21:659–667 ArticlePubMedCAS Google Scholar
Drescher KM, Rogers EJ, Bruce JI, Katz N, Dias LC, Coles GC (1993) Response of drug resistant isolates of Schistosoma mansoni to antischistosomal agents. Mem Inst Oswaldo Cruz 88:89–95 ArticlePubMedCAS Google Scholar
Fallon PG, Doenhoff MJ (1994) Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific. Am J Trop Med Hyg 51:83–88 PubMedCAS Google Scholar
Fallon PG, Sturrock RF, Niang AC, Doenhoff MJ (1994) Diminished susceptibility to praziquantel in a Senegal isolate of Schistosoma mansoni. Am J Trop Med Hyg 53:61–62 Google Scholar
Fenwick A (2012) The global burden of neglected tropical diseases. Public Health 126:233–236 ArticlePubMedCAS Google Scholar
Fenwick A, Savioli L, Engels D, Robert Bergquist N, Todd MH (2003) Drugs for the control of parasitic diseases: current status and development in schistosomiasis. Trends Parasitol 19:509–515 ArticlePubMedCAS Google Scholar
French MD, Churcher TS, Gambhir M, Fenwick A, Webster JP, Kabatereine NB, Basáñez MG (2010) Observed reductions in Schistosoma mansoni transmission from large-scale administration of praziquantel in Uganda: a mathematical modelling study. PLoS Negl Trop Dis 4:e897 ArticlePubMed Google Scholar
Gatti L, Cossa G, Beretta GL, Zaffaroni N, Perego P (2011) Novel insights into targeting ATP-binding cassette transporters for antitumor therapy. Curr Med Chem 18:4237–4249 ArticlePubMedCAS Google Scholar
Geerts S, Coles GC, Gryseels B (1997) Anthelmintic resistance in human helminths: learning from the problems with worm control in livestock. Parasitol Today 13:149–151 ArticlePubMedCAS Google Scholar
Geisler M, Murphy AS (2006) The ABC of auxin transport: the role of p-glycoproteins in plant development. FEBS Lett 580:1094–1102 ArticlePubMedCAS Google Scholar
Glavinas H, Krajcsi P, Cserepes J, Sarkadi B (2004) The role of ABC transporters in drug resistance, metabolism and toxicity. Curr Drug Deliv 1:27–42 ArticlePubMedCAS Google Scholar
Gönnert R, Andrews P (1977) Praziquantel, a new broad-spectrum antischistosomal agent. Parasitol Res 52:129–150 Google Scholar
Greenberg RM (2005) Are Ca2+ channels targets of praziquantel action? Int J Parasitol 35:1–9 ArticlePubMedCAS Google Scholar
Gryseels B, Mbaye A, De Vlas SJ, Stelma FF, Guissé F, Van Lieshout L, Faye D, Diop M, Ly A, Tchuem-Tchuenté LA, Engels D, Polman K (2001) Are poor responses to praziquantel for the treatment of Schistosoma mansoni infections in Senegal due to resistance? An overview of the evidence. Trop Med Int Health 6:864–873 ArticlePubMedCAS Google Scholar
Harder A (2002) Chemotherapeutic approaches to schistosomes: current knowledge and outlook. Parasitol Res 88:395–397 PubMedCAS Google Scholar
Herwaldt BL, Tao LF, van Pelt W, Tsang VC, Bruce JI (1995) Persistence of Schistosoma haematobium infection despite multiple courses of therapy with praziquantel. Clin Infect Dis 20:309–315 ArticlePubMedCAS Google Scholar
Hong QB, Yang K, Huang YX, Sun LP, Yang GJ, Gao Y, Gao Y, Zhang LH, Zhou M, Steinmann P, Liang YS (2011) Effectiveness of a comprehensive schistosomiasis japonica control program in Jiangsu province, China, from 2005 to 2008. Acta Trop 120:S151–S157 ArticlePubMed Google Scholar
Hotez PJ, Fenwick A (2009) Schistosomiasis in Africa: an emerging tragedy in our new global health decade. PLoS Negl Trop Dis 3:e485 ArticlePubMed Google Scholar
Hotez PJ, Savioli L, Fenwick A (2012) Neglected tropical diseases of the Middle East and North Africa: review of their prevalence, distribution, and opportunities for control. PLoS Negl Trop Dis 6:e1475 ArticlePubMed Google Scholar
Huang YX, Xu YL, Yu CX, Li HJ, Yin XR, Wang TS, Wang W, Liang YS (2011) Effect of praziquantel prolonged administration on granuloma formation around Schistosoma japonicum eggs in lung of sensitized mice. Parasitol Res 109:1453–1459 ArticlePubMed Google Scholar
Ismail MM, Taha SA, Farghaly AM, el-Azony AS (1994) Laboratory induced resistance to praziquantel in experimental schistosomiasis. J Egypt Soc Parasitol 24:685–695 PubMedCAS Google Scholar
Ismail M, Metwally A, Farghaly A, Bruce J, Tao LF, Bennett JL (1996) Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high doses of praziquantel. Am J Trop Med Hyg 55:214–218 PubMedCAS Google Scholar
Jansma WB, Rogers SH, Liu CL, Bueding E (1977) Experimentally produced resistance of Schistosoma mansoni to hycanthone. Am J Trop Med Hyg 26:926–936 PubMedCAS Google Scholar
Jeziorski MC, Greenberg RM (2006) Voltage-gated calcium channel subunits from platyhelminths: potential role in praziquantel action. Int J Parasitol 36:625–632 ArticlePubMedCAS Google Scholar
Kasinathan RS, Morgan WM, Greenberg RM (2010a) Schistosoma mansoni express higher levels of multidrug resistance-associated protein 1 (SmMRP1) in juvenile worms and in response to praziquantel. Mol Biochem Parasitol 173:25–31 ArticlePubMedCAS Google Scholar
Kasinathan RS, Goronga T, Messerli SM, Webb TR, Greenberg RM (2010b) Modulation of a Schistosoma mansoni multidrug transporter by the antischistosomal drug praziquantel. FASEB J 24:128–135 ArticlePubMed Google Scholar
Katz N, Dias EP, Araújo N, Souza CP (1973) Estudo de uma cepa humana de Schistosoma mansoni resistente a agentes esquistossomicidas. Rev Soc Bras Med Trop 7:382–387 Google Scholar
Kohn AB, Roberts-Misterly JM, Anderson PA, Khan N, Greenberg RM (2003) Specific sites in the beta interaction domain of a schistosome Ca2+ channel beta subunit are key to its role in sensitivity to the anti-schistosomal drug praziquantel. Parasitology 127:349–356 ArticlePubMedCAS Google Scholar
Koukounari A, Gabrielli AF, Toure S, Bosque-Oliva E, Zhang Y, Sellin B, Donnelly CA, Fenwick A, Webster JP (2007) Schistosoma haematobium infection and morbidity before and after large-scale administration of praziquantel in Burkina Faso. J Infect Dis 196:659–669 ArticlePubMed Google Scholar
Lawn SD, Lucas SB, Chiodini PL (2003) Schistosoma mansoni infection: failure of standard treatment with praziquantel in a returned traveller. Trans R Soc Trop Med Hyg 97:100–101 ArticlePubMed Google Scholar
Leslie J, Garba A, Oliva EB, Barkire A, Tinni AA, Djibo A, Mounkaila I, Fenwick A (2011) Schistosomiasis and soil-transmitted helminth control in Niger: cost effectiveness of school based and community distributed mass drug administration. PLoS Negl Trop Dis 5:e1326 ArticlePubMed Google Scholar
Lespine A, Alvinerie M, Vercruysse J, Prichard RK, Geldhof P (2008) ABC transporter modulation: a strategy to enhance the activity of macrocyclic lactone anthelmintics. Trends Parasitol 24:293–298 ArticlePubMedCAS Google Scholar
Lewis VG, Ween MP, McDevitt CA (2012) The role of ATP-binding cassette transporters in bacterial pathogenicity. Protoplasma, in press
Li HJ, Liang YS, Dai JR, Wang W, Gu GL, Li YZ, Xing YT, Tao YH, Qian K, Jia Y, Yang ZK, Wei JY (2011) Studies on resistance of Schistosoma to praziquantel XIV experimental comparison of susceptibility to praziquantel between praziquantel-resistant isolates and praziquantel-susceptible isolates of Schistosoma japonicum in stages of adult worms, miracidia and cercariae. Chin J Schisto Control 23:611–619 CAS Google Scholar
Liang YS, Dai JR, Ning A, Yu DB, Xu XJ, Zhu YC, Coles GC (2001a) Susceptibility of Schistosoma japonicum to praziquantel in China. Trop Med Int Health 6:707–714 ArticlePubMedCAS Google Scholar
Liang YS, Coles GC, Dai JR, Zhu YC, Doenhoff MJ (2001b) Biological characteristics of praziquantel-resistant and -susceptible isolates of Schistosoma mansoni. Ann Trop Med Parasitol 95:715–723 ArticlePubMedCAS Google Scholar
Liang YS, Wang W, Dai JR, Li HJ, Tao YH, Zhang JF, Li W, Zhu YC, Coles GC, Doenhoff MJ (2010) Susceptibility to praziquantel of male and female cercariae of praziquantel-resistant and susceptible isolates of Schistosoma mansoni. J Helminthol 84:202–207 ArticlePubMedCAS Google Scholar
Liang YJ, Luo J, Yuan Q, Zheng D, Liu YP, Shi L, Zhou Y, Chen AL, Ren YY, Sun KY, Sun Y, Wang Y, Zhang ZS (2011a) New insight into the antifibrotic effects of praziquantel on mice in infection with Schistosoma japonicum. PLoS One 6:e20247 ArticlePubMedCAS Google Scholar
Liang YS, Li HJ, Dai JR, Wang W, Qu GL, Tao YH, Xing YT, Li YZ, Qian K, Wei JY (2011b) Studies on resistance of Schistosoma to praziquantel XIII resistance of Schistosoma japonicum to praziquantel is experimentally induced in laboratory. Chin J Schisto Control 23:605–610 CAS Google Scholar
Martin PJ, Anderson N, Jarrett RG, Brown TH, Ford GE (1982) Effects of a preventive and suppressive control scheme on the development of thiabendazole-resistance in Ostertagia spp. Aust Vet J 58:85–190 Article Google Scholar
Martin PJ, Anderson N, Lwin T, Nelson G, Morgan TE (1984) The association between frequency of thiabendazole treatment and the development of resistance in field isolates of Ostertagia spp. of sheep. Int J Parasitol 14:177–181 ArticlePubMedCAS Google Scholar
Melman SD, Steinauer ML, Cunningham C, Kubatko LS, Mwangi IN, Wynn NB, Mutuku MW, Karanja DM, Colley DG, Black CL, Secor WE, Mkoji GM, Loker ES (2009) Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni. PLoS Negl Trop Dis 3:e504 ArticlePubMed Google Scholar
Messerli SM, Kasinathan RS, Morgan W, Spranger S, Greenberg RM (2009) Schistosoma mansoni P-glycoprotein levels increase in response to praziquantel exposure and correlate with reduced praziquantel susceptibility. Mol Biochem Parasitol 167:54–59 ArticlePubMedCAS Google Scholar
N'Goran EK, Gnaka HN, Tanner M, Utzinger J (2003) Efficacy and side-effects of two praziquantel treatments against Schistosoma haematobium infection, among schoolchildren from Côte d'Ivoire. Ann Trop Med Parasitol 97:37–51 ArticlePubMed Google Scholar
Picquet M, Vercruysse J, Shaw DJ, Diop M, Ly A (1998) Efficacy of praziquantel against Schistosoma mansoni in northern Senegal. Trans R Soc Trop Med Hyg 92:90–93 ArticlePubMedCAS Google Scholar
Renganathan E, Cioli D (1998) An international initiative on praziquantel use. Parasitol Today 14:390–391 ArticlePubMedCAS Google Scholar
Ribeiro-dos-Santos G, Verjovski-Almeida S, Leite LC (2006) Schistosomiasis—a century searching for chemotherapeutic drugs. Parasitol Res 99:505–521 ArticlePubMed Google Scholar
Rodrigues AS, Dinis J, Gromicho M, Martins C, Laires A, Rueff J (2012) Genomics and cancer drug resistance. Curr Pharm Biotechnol 13:651–673 ArticlePubMedCAS Google Scholar
Seto EY, Wong BK, Lu D, Zhong B (2011) Human schistosomiasis resistance to praziquantel in China: should we be worried? Am J Trop Med Hyg 85:74–82 ArticlePubMedCAS Google Scholar
Seubert J, Pohlke R, Loebich F (1977) Synthesis and properties of praziquantel, a novel broad spectrum anthelmintic with excellent activity against schistosomes and cestodes. Experientia 33:1036–1037 ArticlePubMedCAS Google Scholar
Silva IM, Thiengo R, Conceição MJ, Rey L, Lenzi HL, Pereira Filho E, Ribeiro PC (2005) Therapeutic failure of praziquantel in the treatment of Schistosoma haematobium infection in Brazilians returning from Africa. Mem Inst Oswaldo Cruz 100:445–449 PubMed Google Scholar
Silva IM, Pereira Filho E, Thiengo R, Ribeiro PC, Conceição MJ, Panasco M, Lenzi HL (2008) Schistosomiasis haematobia: histopathological course determined by cystoscopy in a patient in whom praziquantel treatment failed. Rev Inst Med Trop Sao Paulo 50:343–346 ArticlePubMed Google Scholar
Stelma FF, Sall S, Daff B, Sow S, Niang M, Gryseels B (1997) Oxamniquine cures Schistosoma mansoni infection in a focus in which cure rates with praziquantel are unusually low. J Infect Dis 176:304–307 ArticlePubMedCAS Google Scholar
Sun LP, Wang W, Liang YS, Tian ZX, Hong QB, Yang K, Yang GJ, Dai JR, Gao Y (2011) Effect of an integrated control strategy for schistosomiasis japonica in the lower reaches of the Yangtze River, China: an evaluation from 2005 to 2008. Parasit Vectors 4:243 ArticlePubMed Google Scholar
Utzinger J, N'Goran EK, N'Dri A, Lengeler C, Tanner M (2000) Efficacy of praziquantel against Schistosoma mansoni with particular consideration for intensity of infection. Trop Med Int Health 5:771–778 ArticlePubMedCAS Google Scholar
Valle C, Troiani AR, Festucci A, Pica-Mattoccia L, Liberti P, Wolstenholme A, Francklow K, Doenhoff MJ, Cioli D (2003) Sequence and level of endogenous expression of calcium channel beta subunits in Schistosoma mansoni displaying different susceptibilities to praziquantel. Mol Biochem Parasitol 130:111–115 ArticlePubMedCAS Google Scholar
Wang W, Liang YS (2007) Progress on research of resistance of schistosome to praziquantel. Int J Med Parasit Dis 34:291–296,300 CAS Google Scholar
Wang LD, Chen HG, Guo JG, Zeng XJ, Hong XL, Xiong JJ, Wu XH, Wang XH, Wang LY, Xia G, Hao Y, Chin DP, Zhou XN (2009a) A strategy to control transmission of Schistosoma japonicum in China. N Engl J Med 360:121–128 ArticlePubMedCAS Google Scholar
Wang LD, Guo JG, Wu XH, Chen HG, Wang TP, Zhu SP, Zhang ZH, Steinmann P, Yang GJ, Wang SP, Wu ZD, Wang LY, Hao Y, Bergquist R, Utzinger J, Zhou XN (2009b) China’s new strategy to block Schistosoma japonicum transmission: experiences and impact beyond schistosomiasis. Trop Med Int Health 14:1475–1483 ArticlePubMed Google Scholar
Wang W, Dai JR, Li HJ, Shen XH, Liang YS (2010) Is there reduced susceptibility to praziquantel in Schistosoma japonicum? Evidence from China. Parasitology 137:1905–1912 ArticlePubMedCAS Google Scholar
Wang W, Dai JR, Li HJ, Shen XH, Liang YS (2012) The sensitivity of Schistosoma japonicum to praziquantel: a field evluation in areas with low endemicity of China. Am J Trop Med Hyg 86:834–836 ArticlePubMed Google Scholar
Wawrzycka D (2011) The ABC transporters of Saccharomyces cerevisiae. Postepy Biochem 57:324–332 PubMed Google Scholar
WHO (1993) The control of schistosomiasis: Second Report of WHO Expert Committee. Geneva: World Health Organization, Technical Report Series, No. 830, Geneva
WHO (2002) Prevention and control of schistosomiasis and soil-transmitted helminthiasis: report of a WHO expert committee. WHO Technical Report Series 912, Geneva
Wu W, Wang W, Huang YX (2011) New insight into praziquantel against various developmental stages of schistosomes. Parasitol Res 109:1501–1507 ArticlePubMed Google Scholar
Xianyi C, Liying W, Jiming C, Xiaonong Z, Jiang Z, Jiagang G, Xiaohua W, Engels D, Minggang C (2005) Schistosomiasis control in China: the impact of a 10-year World Bank Loan Project (1992–2001). Bull World Health Organ 83:43–48 PubMed Google Scholar
Xiao SH, Mei JY, Jiao PY (2009) The in vitro effect of mefloquine and praziquantel against juvenile and adult Schistosoma japonicum. Parasitol Res 106:237–246 ArticlePubMed Google Scholar
Xiao SH, Keiser J, Chen MG, Tanner M, Utzinger J (2010) Research and development of antischistosomal drugs in the People’s Republic of China a 60-year review. Adv Parasitol 73:231–295 ArticlePubMed Google Scholar
Xiao SH, Mei JY, Jiao PY (2011) Effect of mefloquine administered orally at single, multiple, or combined with artemether, artesunate, or praziquantel in treatment of mice infected with Schistosoma japonicum. Parasitol Res 108:399–406 ArticlePubMed Google Scholar
Xiao SH, Xue J, Zhang HB (2012) Further studies on mefloquine and praziquantel alone or interaction of both drugs against Schistosoma japonicum in vitro. Parasitol Res 110:1239–1248 ArticlePubMed Google Scholar
Yu DB, Li Y, Sleigh AC, Yu XL, Li YS, Wei WY, Liang YS, McManus DP (2001) Efficacy of praziquantel against Schistosoma japonicum: field evaluation in an area with repeated chemotherapy compared with a newly identified endemic focus in Hunan, China. Trans R Soc Trop Med Hyg 95:537–541 ArticlePubMedCAS Google Scholar
Yue WJ, Yu SH, Xu XJ (1990) Failure to induce resistance of Schistosoma japonicum to praziquantel. Southeast Asian J Trop Med Public Health 21:85–89 PubMedCAS Google Scholar
Zhai ZL, Xiao SH, Chen MG, Zheng J (1999) A worrying problem: is there resistance of schistosome to praziquantel? Chin J Schisto Control 11:121–124 Google Scholar
Zhang Y, Koukounari A, Kabatereine N, Fleming F, Kazibwe F, Tukahebwa E, Stothard JR, Webster JP, Fenwick A (2007) Parasitological impact of 2-year preventive chemotherapy on schistosomiasis and soil-transmitted helminthiasis in Uganda. BMC Med 5:27 ArticlePubMed Google Scholar